tICAM-1

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NametICAM-1
Drug Alias Nametruncated ICAM-1tICAM-rhinovirustICAM453
ClassificationOther
Mechanisms of ActionSelectins inhibitors
TargetsSelectins
Therapy Area/IndicationsRhinovirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsRhinovirus infection

Other Information

ATC CodeN/A
Related LinksN/A